Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2026 08:30 ET | Source: Green Shift Commodities Ltd.

Jaguar Uranium US$25M IPO Underscores Value in Green Shift Commodities

TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Green Shift Commodities Ltd. (TSXV: GCOM; OTCQB: GRCMF) (“Green Shift,” “GCOM,” or the “Company”) is pleased to announce that Jaguar Uranium Corp. (“Jaguar...
February 11, 2026 08:00 ET | Source: Insight Molecular Diagnostics Inc.

iMDx Announces $26.0 Million Registered Direct Offering

NASHVILLE, Tenn., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (“iMDx” or the “Company”), today announced that it has entered into definitive agreements with...
February 10, 2026 23:23 ET | Source: SOLV Energy, Inc.

SOLV Energy Announces Pricing of Initial Public Offering

SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”), a leading provider of infrastructure services to the power industry, today announced the pricing of its...
February 09, 2026 20:00 ET | Source: Spring Valley Acquisition Corp

Spring Valley Acquisition Corp. IV Announces Pricing of $200 Million Initial Public Offering

Spring Valley Acquisition Corp. IV Announces Pricing of $200 Million Initial Public Offering
February 09, 2026 17:00 ET | Source: SPACSphere Acquisition Corp.

SPACSphere Acquisition Corp. Announces the Closing of $172,500,000 Initial Public Offering

GRAND CAYMAN, Cayman Islands, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SPACSphere Acquisition Corp. (the “Company”) (Nasdaq: SSACU) today announced the closing of its initial public offering of 17,250,000...
February 09, 2026 16:05 ET | Source: AgomAb Therapeutics N.V.

Agomab Announces Closing of Initial Public Offering

Agomab Therapeutics NV today announced the closing of its previously announced initial public offering of 12,500,000 American Depositary Shares (“ADSs”)
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the closing of its previously announced underwritten public offering...
February 06, 2026 09:25 ET | Source: Ernexa Therapeutics Inc.

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics Inc. (Nasdaq: ERNA) (“Ernexa” or the “Company”), an industry innovator developing novel cell therapies for the treatment of...
February 06, 2026 08:00 ET | Source: Liberty Defense

Liberty Defense Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering

WILMINGTON, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Liberty Defense Holdings, Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30) today announced that it has publicly filed a...
February 06, 2026 07:45 ET | Source: Cambridge Acquisition Corp.

Cambridge Acquisition Corp. Announces the Pricing of $200 Million Initial Public Offering

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cambridge Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by...